Evidence map›Paper›PMID 25807284›Full record

ArticleNature genetics2015

Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia.

Leila Noetzli, Richard W Lo, Alisa B Lee-Sherick, Michael Callaghan, Patrizia Noris, Anna Savoia, Madhvi Rajpurkar, Kenneth Jones, Katherine Gowan, Carlo Balduini and 18 more

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 139 papers.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed
26.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 324 citations in OpenAlex.

  1. A GermlineEJHaem · 2026
    Article
  2. Article
  3. Article
  4. Importin-9 recognizes the winged-helix fold of ETS transcription factors to mediate nuclear import.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. A germlineScience advances · 2025
    Article
  18. Article
  19. Review
  20. Article

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 11 institutions in 5 countries.

Leila Noetzli *Department of Pediatrics, University of Colorado Anschutz Medical Campus (AMC), Aurora, Colorado, CO, USA.
Richard W Lo *Program in Cell Biology, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
Alisa B Lee-SherickDepartment of Pediatrics, University of Colorado Anschutz Medical Campus (AMC), Aurora, Colorado, CO, USA.
Michael CallaghanChildren's Hospital of Michigan, Wayne State University, Detroit, MI, USA.
Patrizia NorisDepartment of Internal Medicine, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy.
Anna SavoiaDepartment of Medical Sciences, University of Trieste, Trieste, Italy.
Madhvi RajpurkarChildren's Hospital of Michigan, Wayne State University, Detroit, MI, USA.
Kenneth JonesDepartment of Biochemistry and Molecular Genetics, University of Colorado AMC, Aurora, Colorado, USA.
Katherine GowanDepartment of Biochemistry and Molecular Genetics, University of Colorado AMC, Aurora, Colorado, USA.
Carlo BalduiniDepartment of Internal Medicine, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy.
Alessandro PecciDepartment of Internal Medicine, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy.
Chiara GnanDepartment of Medical Sciences, University of Trieste, Trieste, Italy.
Daniela De RoccoDepartment of Medical Sciences, University of Trieste, Trieste, Italy.
Michael DoubekDepartment of Internal Medicine, Haematology/Oncology, University Hospital Brno, CZ.
Ling LiProgram in Cell Biology, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
Lily LuProgram in Cell Biology, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
Richard LeungProgram in Cell Biology, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
Carolina Landolt-MarticorenaDepartment of Medicine, University of Toronto, Division of Rheumatology University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada.
Stephen HungerDepartment of Pediatrics, University of Colorado Anschutz Medical Campus (AMC), Aurora, Colorado, CO, USA.
Paula HellerInstituto de Investigaciones Medicas Alfredo Lanari, Universidad de Buenos Aires, Buenos Aires, Argentina.
Arthur Gutierrez-HartmannDepartment of Biochemistry and Molecular Genetics, University of Colorado AMC, Aurora, Colorado, USA.
Liang XiayuanDepartment of Pathology, University of Colorado, AMC, Aurora, Colorado, USA.
Fred G PlutheroProgram in Cell Biology, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
Jesse W RowleyDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
Andrew S WeyrichDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
Walter H A Kahr *Program in Cell Biology, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
Christopher C Porter *Department of Pediatrics, University of Colorado Anschutz Medical Campus (AMC), Aurora, Colorado, CO, USA.
Jorge Di Paola *Department of Pediatrics, University of Colorado Anschutz Medical Campus (AMC), Aurora, Colorado, CO, USA.
Hospital for Sick Children · CAUniversity of Colorado Anschutz Medical Campus · USUniversity of Toronto · CAUniversity of Trieste · ITChildren's Hospital of Michigan · USIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Utah · USInstitute for Medical Research · ARUniversity Hospital Brno · CZUniversity of Colorado Denver · USUniversity of Pavia · IT

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Translational Research Skills Development CoreU54HL112311 · NHLBI · UNIVERSITY OF UTAH · PI WEYRICH, ANDREW S · 2012 to 2016
$12.9M
A Systems Biology Approach to Predicting Bleeding in HemophiliaR01HL120728 · NHLBI · COLORADO SCHOOL OF MINES · PI DI PAOLA, JORGE A, FOGELSON, AARON L · 2014 to 2018
$2.7M
The Platelet Metabolome in ObesityK01GM103806 · NIGMS · UNIVERSITY OF UTAH · PI ROWLEY, JESSE · 2012 to 2016
$802k
CIHR MOP-259952CIHR MOP-81208NCATS NIH HHS UL1 TR001082NCI NIH HHS P30 CA046934NHLBI NIH HHS HL112311NHLBI NIH HHS R01 HL120728NHLBI NIH HHS U54 HL112311NIGMS NIH HHS GM103806NIGMS NIH HHS K01 GM103806Telethon GGP13082
6 · The paper itself

Abstract

Some familial platelet disorders are associated with predisposition to leukemia, myelodysplastic syndrome (MDS) or dyserythropoietic anemia. We identified a family with autosomal dominant thrombocytopenia, high erythrocyte mean corpuscular volume (MCV) and two occurrences of B cell-precursor acute lymphoblastic leukemia (ALL). Whole-exome sequencing identified a heterozygous single-nucleotide change in ETV6 (ets variant 6), c.641C>T, encoding a p.Pro214Leu substitution in the central domain, segregating with thrombocytopenia and elevated MCV. A screen of 23 families with similar phenotypes identified 2 with ETV6 mutations. One family also had a mutation encoding p.Pro214Leu and one individual with ALL. The other family had a c.1252A>G transition producing a p.Arg418Gly substitution in the DNA-binding domain, with alternative splicing and exon skipping. Functional characterization of these mutations showed aberrant cellular localization of mutant and endogenous ETV6, decreased transcriptional repression and altered megakaryocyte maturation. Our findings underscore a key role for ETV6 in platelet formation and leukemia predisposition.

Indexed as

AdultChild, PreschoolDNA Mutational AnalysisErythrocytes, AbnormalETS Translocation Variant 6 ProteinExomeFemaleGenetic Association StudiesGenetic Predisposition to DiseaseGerm-Line MutationHEK293 CellsHematologic DiseasesHumansMaleMutation, MissensePedigreeETS Translocation Variant 6 ProteinProto-Oncogene Proteins c-etsRepressor Proteins

Identifiers

PMID25807284
PMCPMC4631613
OpenAlexW1970504500

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.